JP2008514588A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008514588A5 JP2008514588A5 JP2007533418A JP2007533418A JP2008514588A5 JP 2008514588 A5 JP2008514588 A5 JP 2008514588A5 JP 2007533418 A JP2007533418 A JP 2007533418A JP 2007533418 A JP2007533418 A JP 2007533418A JP 2008514588 A5 JP2008514588 A5 JP 2008514588A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- contrast agent
- leu
- trp
- phe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO20044139 | 2004-09-29 | ||
| NO20044139 | 2004-09-29 | ||
| PCT/NO2005/000362 WO2006036071A2 (en) | 2004-09-29 | 2005-09-28 | Urokinase plasminogen activator receptor targeted contrast agent |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008514588A JP2008514588A (ja) | 2008-05-08 |
| JP2008514588A5 true JP2008514588A5 (https=) | 2008-11-06 |
| JP5122962B2 JP5122962B2 (ja) | 2013-01-16 |
Family
ID=35930012
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007533418A Expired - Fee Related JP5122962B2 (ja) | 2004-09-29 | 2005-09-28 | ｕＰＡＲターゲティング造影剤 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8568689B1 (https=) |
| EP (1) | EP1796733A2 (https=) |
| JP (1) | JP5122962B2 (https=) |
| KR (1) | KR101248350B1 (https=) |
| CN (1) | CN101065152A (https=) |
| AU (1) | AU2005287934B2 (https=) |
| BR (1) | BRPI0516168A (https=) |
| CA (1) | CA2580464A1 (https=) |
| MX (1) | MX2007003750A (https=) |
| RU (1) | RU2394837C2 (https=) |
| WO (1) | WO2006036071A2 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007044892A2 (en) * | 2005-10-10 | 2007-04-19 | American Diagnostica, Inc. | Upar-binding molecule-drug conjugates and uses thereof |
| JP2010513476A (ja) * | 2006-12-20 | 2010-04-30 | ジーイー・ヘルスケア・アクスイェ・セルスカプ | 造影剤 |
| GB0718967D0 (en) * | 2007-09-28 | 2007-11-07 | Ge Healthcare Ltd | Peptide imaging agents |
| GB0718957D0 (en) * | 2007-09-28 | 2007-11-07 | Ge Healthcare Ltd | Optical imaging agents |
| EP2598175B1 (en) | 2010-07-27 | 2020-05-20 | Serac Healthcare Limited | Radiopharmaceutical compositions |
| CA2905172C (en) * | 2012-05-08 | 2021-07-20 | Andreas Kjaer | 177-lu labeled peptide for site-specific upar-targeting |
| CA3221851A1 (en) | 2012-12-03 | 2014-06-12 | Curasight A/S | Positron emitting radionuclide labeled peptides for human upar pet imaging |
| CA2961095C (en) * | 2014-09-17 | 2021-02-09 | Rigshospitalet | Upar targeting peptide for use in perioperative optical imaging of invasive cancer |
| US20210138090A1 (en) * | 2014-09-17 | 2021-05-13 | Fluoguide A/S | uPAR targeting peptide for use in peroperative optical imaging of invasive cancer |
| AU2016271853B2 (en) * | 2015-06-03 | 2020-10-22 | Surgimab S.A.S. | Fluorescent conjugates |
| EP3759121A1 (en) | 2018-03-01 | 2021-01-06 | Trigemina, Inc. | Labeled oxytocin and method of manufacture and use |
| EP3999094B1 (en) * | 2019-07-16 | 2026-02-25 | Rigshospitalet | A urokinase plasminogen activator receptor-targeting peptide |
| WO2021009219A1 (en) * | 2019-07-16 | 2021-01-21 | Fluoguide A/S | A receptor-targeting conjugate with an effective pharmacokinetic profile |
| US20240009331A1 (en) * | 2020-12-01 | 2024-01-11 | Curasight A/S | Urokinase plasminogen activator receptor targeted radiolabeled peptide conjugates |
| US20240066142A1 (en) * | 2021-01-15 | 2024-02-29 | Fluoguide A/S | A upar (urokinase plasminogen activator receptor)-targeting conjugate |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6120765A (en) | 1993-04-02 | 2000-09-19 | Shiseido Co. Ltd. | Urokinase plasminogen activator fragments |
| US6277818B1 (en) * | 1998-10-29 | 2001-08-21 | Angstrom Pharmaceuticals, Inc. | Cyclic peptide ligands that target urokinase plasminogen activator receptor |
| US5942492A (en) * | 1996-11-12 | 1999-08-24 | Angstrom Pharmaceuticals, Inc. | Cyclic peptides that bind to urokinase-type plasminogen activator receptor |
| GB9705521D0 (en) * | 1997-03-18 | 1997-05-07 | Univ Sheffield | The use of mononuclear phagocytes in the vivo imaging of hypoxic/ischaemic tissue |
| AR020101A1 (es) * | 1998-07-01 | 2002-04-10 | Cancerforskingsfonden Af 1989 | Un antagonista peptido del receptor de uroquinasa humana, composicion farmaceutica que lo contiene, su uso para la manufactura de un medicamento y metodopara seleccionar un antagonista peptido adecuado. |
| US6896870B1 (en) * | 1999-10-01 | 2005-05-24 | Angstrom Pharmaceuticals, Inc. | Diagnostic probes and therapeutics targeting uPA and uPAR |
| WO2001025410A2 (en) * | 1999-10-01 | 2001-04-12 | Angstrom Pharmaceuticals, Inc. | DIAGNOSTIC PROBES AND THERAPEUTICS TARGETING uPA AND uPAR |
| RU2165266C1 (ru) * | 2000-06-28 | 2001-04-20 | Центральный научно-исследовательский рентгенорадиологический институт | Способ получения [2-18f]-2-дезоксиглюкозы |
| JP2007526300A (ja) * | 2004-03-04 | 2007-09-13 | ジーイー・ヘルスケア・アクスイェ・セルスカプ | 医薬化合物 |
-
2005
- 2005-09-28 MX MX2007003750A patent/MX2007003750A/es active IP Right Grant
- 2005-09-28 EP EP05788552A patent/EP1796733A2/en not_active Withdrawn
- 2005-09-28 CA CA002580464A patent/CA2580464A1/en not_active Abandoned
- 2005-09-28 US US11/576,193 patent/US8568689B1/en not_active Expired - Fee Related
- 2005-09-28 RU RU2007111467/04A patent/RU2394837C2/ru not_active IP Right Cessation
- 2005-09-28 WO PCT/NO2005/000362 patent/WO2006036071A2/en not_active Ceased
- 2005-09-28 AU AU2005287934A patent/AU2005287934B2/en not_active Ceased
- 2005-09-28 JP JP2007533418A patent/JP5122962B2/ja not_active Expired - Fee Related
- 2005-09-28 KR KR1020077007004A patent/KR101248350B1/ko not_active Expired - Fee Related
- 2005-09-28 CN CNA2005800408838A patent/CN101065152A/zh active Pending
- 2005-09-28 BR BRPI0516168-1A patent/BRPI0516168A/pt not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008514588A5 (https=) | ||
| JP2005519041A5 (https=) | ||
| JP2011518179A5 (https=) | ||
| RU2594167C2 (ru) | Композиции пептидных радиоактивных индикаторов | |
| JP2020502051A5 (https=) | ||
| Indrevoll et al. | NC-100717: a versatile RGD peptide scaffold for angiogenesis imaging | |
| JP2007535493A5 (https=) | ||
| RU2008141280A (ru) | Агонисты рецептора нейромедина u и их применение | |
| CN1158133A (zh) | 肽衍生的放射性核素螯合剂 | |
| CA2405469A1 (en) | Integrin binding peptide derivatives | |
| WO2007082483B1 (en) | Medicament for treatment of tumor and the use thereof | |
| IL316406A (en) | Lipid-modified relaxin B peptide chains and their medical use | |
| JP6633523B2 (ja) | Ｐｓｄ−９５の二量体阻害剤脂肪酸誘導体 | |
| JP2012506408A5 (https=) | ||
| KR20230051583A (ko) | Crf2 수용체 작용제 및 치료에서의 이의 용도 | |
| JP2013531660A5 (https=) | ||
| WO2021226432A2 (en) | Methods of detecting and treating lung damage in respiratory-related viral infections | |
| JP2024520234A (ja) | Ｐｓｄ－９５阻害剤及びその使用 | |
| RU2013146690A (ru) | Циклические пептиды с антинеопластической и антиангионенной активностью | |
| RU2007111467A (ru) | Контрастный агент, нацеленный на рецептор урокиназного активатора плазминогена | |
| AU2019335513A1 (en) | Alpha(v)beta(6) integrin-binding peptides and methods of use thereof | |
| CN103961722A (zh) | 一种靶向光声造影剂、其制备方法及应用 | |
| JP2010502585A5 (https=) | ||
| CN1309661A (zh) | 标记的谷氨酰胺和赖氨酸类似物 | |
| CN105148289B (zh) | 一种两亲性寡聚多肽药物结合物 |